Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seanova is a French biotechnology company specializing in the development and distribution of sustainable marine-sourced ingredients for the nutraceutical, cosmetic, and pharmaceutical industries. Headquartered in Brest, the company leverages the rich biodiversity of the marine environment to offer high-quality bioactives, including microalgae-derived omega-3 (DHA), marine minerals, and seaweed extracts. Seanova is particularly recognized for its expertise in plant-based marine alternatives, providing vegan-friendly DHA oils produced through controlled fermentation processes. Their product portfolio supports a wide range of health applications, including cognitive function, cardiovascular health, and bone density. In addition to ingredient supply, Seanova provides technical, scientific, and regulatory support to help clients formulate innovative and effective health products. The company emphasizes sustainability and traceability throughout its supply chain to meet the growing demand for eco-conscious wellness solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seanova.